JPRN-UMIN000022985已完成未知
Effect of Denosumab and Alendronate on osteoporosis in hemodialysis patients :a randomized controlled trial - Effect of Denosumab and Alendronate on osteoporosis in hemodialysis patients :a randomized controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •) Patients who are considered to be contraindicated for denosumab. 2) Patients who are considered to be contraindicated for alendronate. 3) Cancer patients. 4) Patients who have pretreated with bisphosphonate in recent 6 months. 5) Patients who have pretreated with denosumab in recent 6 months. 6) Patients whose corrected Ca is less than 8.4 mg/dL. 7) Patients with severe liver disease 8) Patients with severe heart disease 9) Patients may be pregnant 10) Patients who have bad oral consitions 11) Patients who are thought to be inappropriate for this study by physician.
研究者
相似试验
已完成
不适用
The effect of denosmab on osteoporosis related to Parkinson's disease and glucocorticoid-induced osteoporosisJPRN-UMIN000025056The Jikei University School of Medicine40
已完成
不适用
Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritisRheumatoid ArthritisJPRN-UMIN000042107Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine200
进行中（未招募）
不适用
A clinical trial to find out whether a medication, called denosumab, has an effect on the bone surrounding a hip joint replacementEUCTR2011-000541-20-GBSheffield Teaching Hospitals NHS Foundation Trust30
已完成
4 期
Effects of long-acting alendronate on osteoporosis with impaired glucose metabolismOsteoporosisJPRN-UMIN000000987ational Hospital Organization, Kyoto Medical Center100
招募中
2 期
Effect of denosumab and zoledronic acid on bone turnover markers in critically ill womeOsteoporosisACTRN12617000545369niversity Hospital Geelong30